Illumina to take $1.47 billion impairment charge related to Grail in Q2
June 27 (Reuters) - Illumina ILMN.O said on Thursday it will take a goodwill impairment charge of $1.47 billion in the second quarter related to the recently spun-off Grail Inc GRAL.O . (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli) ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))
Recent news on Grail
See all newsGrail rises as TD Cowen more than doubles PT on FDA, Medicare optimism
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, Tesla
Street View: Grail cancer test's progress boosts prospects for multi-cancer detection market
NASDAQ RESUMED AT 07:05 AM